CREO - Microwave Ablation Feasibility Study
NCT: NCT07817147 · RECRUITING
Brief Summary
The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety of treatment with the device and the antitumor effect following treatment with the device.
Frequently Asked Questions
What is CREO - Microwave Ablation Feasibility Study?
CREO - Microwave Ablation Feasibility Study is a clinical trial registered under NCT07817147. Current status: RECRUITING.
What is the status of NCT07817147?
The current status of NCT07817147 (CREO - Microwave Ablation Feasibility Study) is: RECRUITING.
When did CREO - Microwave Ablation Feasibility Study start?
CREO - Microwave Ablation Feasibility Study started on 2026-02-19.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.